Confronting State Medicaid Drug Spending Pressures

In the context of declining state Medicaid revenues and rising enrollment related due to coronavirus disease 2019, this Viewpoint proposes policy and payment reforms related to mandated drug coverage and manufacturer rebates that could assist states financially while maintaining patient access to life-saving medications.
Source: JAMA - Category: General Medicine Source Type: research